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Rubella virus (RV) virions contain, in addition to the RNA genome, a capsid protein (C) and two envelope glycoproteins
(E1 and E2). The C protein in isolated virions has been reported to be a disulfide-linked dimer (C2). There are two cysteine
residues (Cys-152 and Cys-196) within the C protein. To define the role of disulfide-linked C2 dimer in virion formation, site-
directed mutagenesis was used to alter the Cys-152 residue to serine. The association of mutant C protein with envelope
glycoproteins was examined by transient expression of the cDNAs in COS cells. Mutation at the Cys-152 residue completely
abolished the formation of C2 dimer. However, C2 dimerization does not appear to be important for the assembly of RV
structural proteins into virus-like particles. q 1996 Academic Press, Inc.
Rubella virus (RV), a single-stranded, positive polarity In RV-infected cells, virions have been shown to bud
RNA virus, is the only member of the Rubivirus genus from a variety of sites such as the Golgi complex, intracel-
within the family Togaviridae (1). The RV virion contains lular vacuoles, and plasma membrane (7, 8). In vitro stud-
a nucleocapsid consisting of a 40S genomic RNA and ies in transfected cells expressing C, E2, and E1 appear
multiple copies of a single species of capsid protein to support the intracellular budding of RV (9, 10). These
(C). The nucleocapsid is surrounded by a host-derived studies showed that all three RV structural proteins are
envelope membrane containing two glycoproteins, E1 (57 targeted predominantly to the Golgi complex after initial
kDa) and E2 (42–47 kDa). In RV-infected cells, the 40S processing in the endoplasmic reticulum (ER) with only
viral genomic RNA serves as a template for the synthesis a small proportion of E1 and E2 detectable on the plasma
of a 24S subgenomic RNA which is identical to the 3*- membrane. The retention of E1 and E2 in the Golgi com-
terminal one-third of the viral genome (2). Translation of plex facilitates the budding of virus-like particles (VLPs)
the 24S subgenomic mRNA produces a 110-kDa poly- from these sites (10).
protein precursor (p110) which is proteolytically cleaved The assembly process of RV structural proteins lead-
and then processed to yield the three RV structural pro- ing to virus budding is not well understood. It has recently
teins (2). Pulse-chase studies and nucleotide sequence been shown that the capsid protein plays an important
analysis have shown that the gene order of p110 is NH2 – role in triggering the formation of VLPs because it medi-
C–E2–E1–COOH (2 – 4). In this respect, the replication ates the assembly of RV spike proteins on Golgi mem-
strategy and genomic organization of RV is similar to the branes (11). RV capsid protein is associated with mem-
members of the Alphavirus genus (4). branes and the attachment of the E2 signal sequence at
In RV virions, E1 and E2, exist as a heterodimer and the carboxy terminus of the capsid protein presumably
C is found as a disulfide-bonded homodimer (5, 6). In mediates this association (12). This is in contrast to the
contrast, disulfide-bonding has not been detected for alphavirus capsid protein which is an autoprotease (13,
alphavirus capsid protein. Amino acid sequence analysis 14). For the alphaviruses, the newly released capsid pro-
showed that the C protein is hydrophilic and contains tein rapidly associates with the viral genomic RNA to
high proportions of positively charged arginine and lysine form nucleocapsids (15).
clustered at the amino-terminal and carboxy-terminal Previous studies on the assembly of RV structural pro-
ends (3). It is suggested that these clusters of amino teins reported that in RV-infected cells, capsid protein
acids may be involved in binding to the negatively first formed noncovalent dimers that spontaneously be-
charged genomic RNA. came disulfide-linked (6). Dimerization of the capsid pro-
tein was found to be independent of the presence of E1
and E2, or of virion formation. To further understand the
1 Present address: Macfarlane Burnet Center for Medical Research, role of disulfide-linked capsid dimers in virion formation,P.O. Box 254, Fairfield, Victoria, Australia, 3078.
site-directed mutagenesis was employed to alter one of2 To whom correspondence and reprint requests should be ad-
dressed. the two cysteine residues (Cys-152 and Cys-196) on the
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capsid protein. RV cDNA encoding C has been previously
subcloned into pCMV5, a eukaryotic expression vector
containing the human cytomegalovirus immediate early
gene promoter (16). For construction of the mutant, the
entire RV C coding region was excised from pCMV5-C
using EcoRI and XbaI, and subcloned into M13mp18. The
mutant was prepared by oligonucleotide-directed muta-
genesis on single-stranded uracil-containing templates
(17). The mutagenic oligonucleotide used was pAGGTC-
ACGCTGGCCTC (the altered nucleotide is underlined),
FIG. 1. Immunoblot analysis of pCMV5-C- and pCMV5-DC-complementary to the nucleotides 587–604 (3) and which
transfected COS cells. COS cells grown in 35-mm dishes were mockchanged Cys-152 to Ser. The mutation also abolished
transfected (lanes 1 and 5) or transfected with 2 mg of pCMV5 (lanesthe StuI site within this region and the resulting mutants, 2 and 6), 2 mg of pCMV5-C (lanes 4 and 8), or 2 mg of pCMV5-DC
designated M13mp18-DC, were selected by the inability (lanes 3 and 7). Transfected COS cells were solubilized in RIPA buffer
of the restriction enzyme, StuI, to linearize the recombi- (1% Triton X-100; 10 mM EDTA; 50 mM Tris–HCl, pH 7.5; 1% sodium
deoxycholate; 0.15 M NaCl; 0.1% SDS) containing 10 mM iodoacet-nant plasmid. The cDNA was then subcloned into pCMV5
amide. Cell lysates were denatured in the absence or presence of 2-and used for transfection studies in COS cells.
mercaptoethanol, subjected to SDS–PAGE, and transferred to a nitro-COS cells were grown in 35-mm dishes and cellulose membrane. The membrane was probed with human anti-
transfected with the recombinant plasmids using Lipo- RV serum and processed for ECL following reactivity to peroxidase-
fectin (Gibco/BRL) as described previously (18). At 48 hr conjugated rabbit anti-human IgG. The monomeric form (C) and the
dimeric form (C–C) of the capsid are indicated. Relative mobilities ofposttransfection, cells were solubilized in RIPA buffer (1%
protein standards (kDa) are shown on the left.(w/v) Triton X-100; 100 mM EDTA; 50 mM Tris–HCl, pH
7.5; 1% (w/v) sodium deoxycholate; 150 mM NaCl; 0.1%
(w/v) SDS) containing 10 mM iodoacetamide. Iodoacet- tion. However, the nature of covalent bonding is not
known. It is possible that some of the wild-type capsidamide was added to prevent formation of disulfide link-
ages which can occur from the oxidation conditions of monomers as seen under nonreducing conditions un-
dergo intramolecular disulfide bonding.the lysis buffer. The subsequent protein samples were
denatured in the presence or absence of 2-mercaptoeth- Recent stable and transient transfection studies have
shown that C, E1, and E2 are secreted into the mediumanol, separated by sodium dodecyl sulfate–polyacryl-
amide gel electrophoresis (SDS–PAGE), and transferred in the form of VLPs (10, 11). These studies showed that
the release of RV structural proteins into the media isto nitrocellulose membranes for immunoblot analysis.
The membranes were probed with human anti-RV serum dependent on the coexpression of the capsid protein.
To investigate whether VLPs can still be formed in theand then processed for enhanced chemiluminescence
(ECL) (Amersham) following reactivity with peroxidase- presence of mutant capsid protein, a recombinant plas-
mid encoding mutant C and wild-type E1 and E2 (DC–conjugated rabbit anti-human IgG (Dako, CA). Under re-
ducing conditions the wild-type and mutant C proteins E2–E1) was constructed. A fragment from a previously
constructed pCMV5-24S encoding all three structuralwere observed in monomeric forms (Fig. 1, lanes 7 and
8). The absence of this monomer in mock-transfected proteins (9) was excised using SphI (located within the C
coding region) and HindIII and subcloned into M13mp18-cells or in cells transfected with the vector only (Fig. 1,
lane 5 and 6) confirmed that this protein is virus specific. DC. The resultant fragment encoding DC–E2–E1 was
then excised using EcoR1 and HindIII and subclonedWhen the same samples were analyzed under nonreduc-
ing conditions, two distinct protein species of 34 and 68 into the expression vector pCMV5 (16). COS cells were
transfected with equivalent amounts of pCMV5-24S orkDa were observed in cells transfected with wild-type
cDNA (Fig. 1, lane 4). In contrast, in cells transfected pCMV5-DC–E2–E1 using Lipofectin. The cells were har-
vested 48 hr later and processed for immunoblot analysiswith mutant cDNA only the monomeric form was de-
tected (Fig. 1, lane 3). The appearance of the 68-kDa using human anti-RV serum. Under nonreducing condi-
tions, all three structural proteins corresponding to RVprotein in the nonreduced wild-type preparation indi-
cated the presence of oligomeric forms of C protein, virion proteins were detected in pCMV5-24S- and
pCMV5-DC–E2–E1-transfected COS cells (Fig. 2A,which corresponded to the reported dimeric form of C
(5, 6). The absence of the dimeric species of C protein lanes 3 to 5). These proteins were not seen in mock-
transfected cells or cells transfected with the vector,from cells transfected with mutant cDNA indicated that
Cys-152 residue in capsid protein is required for dimer- pCMV5 (Fig. 2A, lanes 2 and 3). Whereas wild-type C
was seen predominantly as a dimer (68 kDa) (Fig. 2A,ization. Under nonreducing conditions, the wild-type C
monomer is still present, suggesting that not all of the lane 4), mutant C protein was only observed as a 34-kDa
monomeric species (Fig. 2A, lanes 5 and 6). The dimericmonomers become dimerized. The presence of two cys-
teine residues within the capsid monomer allows for in- form of C was still not detectable in COS cells transfected
with double the amount of mutant cDNA (Fig. 2A, lanetramolecular or intermolecular bonding for dimer forma-
/ m4950$7676 01-04-96 19:10:53 viral AP-Virology
225SHORT COMMUNICATION
FIG. 2. Immunoblot analysis of pCMV5-24S- and pCMV5-DC–E2–E1-transfected COS cells using human anti-RV serum. (A) Lipofectin was used
for mock transfection of COS cells (lane 2) or to transfect COS cells with 2 mg of pCMV5 (lane 3), 2 mg of pCMV5-24S (lane 4), 2 mg of pCMV5-
DC–E2–E1 (lane 5), or 4 mg of pCMV5-DC–E2–E1 (lane 6). Cell lysates were harvested 48 hr later and processed under nonreducing conditions
for immunoblot analysis. Disrupted RV virions (lane 1) were included to indicate the relative positions of RV structural proteins and the dimeric
forms of E1– E1 and E1–E2 under reducing conditions. (B) COS cells grown in 75-cm2 flasks were transfected with 18 mg of pCMV5 (lanes 1 and
4), pCMV5-24S (lanes 2 and 5), or pCMV5-DC–E2–E1 (lanes 3 and 6). The culture fluid and cells were harvested 48 hr later and processed as
follows. The culture fluid was clarified at 10,000 g for 10 min at 47 and 40% (w/v) PEG 6000 was added to a final concentration of 8% (w/v) for the
precipitation of VLPs. After 2 hr at 47 VLPs were pelleted at 10,000 g for 45 min at 47 and resuspended in lysate buffer. The cell lysates (lanes 1,
2, and 3) and VLP preparations (4, 5, and 6) were processed under nonreducing conditions for immunoblot analysis. The positions of E1, E2, capsid
monomer (C), and capsid dimer (C–C) are shown. Relative mobilities of protein standards (kDa) are shown on the left.
6). The protein species with apparent molecular weights Indirect immunofluorescence assay using human anti-
RV serum and mouse monoclonal antibodies to C, E2,of 114 and 94 kDa (Fig. 2) are the dimeric forms of E1–
E1 and E1–E2, respectively (19). and E1 was employed to determine the intracellular lo-
calization of mutant C, E2, and E1. To identify Golgi struc-COS cells transiently expressing RV structural proteins
were found to secrete viral antigens into the medium as tures, acetone-fixed cells were first treated with tetra-
methylrhodamine isothiocyanate (TRITC)-conjugatedVLPs in a capsid-dependent manner (11), although the
process was not as efficient as that in stably transformed wheat germ agglutinin (WGA) (Sigma) (20). After the re-
moval of TRITC-WGA, the cells were treated with humancell lines (10, 11). To determine the effect of mutant cap-
sid protein on its ability to form VLPs, COS cells grown anti-RV serum or mouse monoclonal antibodies to C, E2,
or E1 and then reacted with the appropriate fluoresceinin 75-cm2 flasks were transfected with equal amounts
of pCMV5, pCMV5-24S, or pCMV5-DC–E2–E1. For the isothiocyanate-conjugated (FITC) IgG (9). When reacted
with human anti-RV serum or antibodies to individual C,isolation of VLPs from culture medium, the conventional
polyethylene glycol (PEG) precipitation procedure for the E2, or E1, pCMV5-24S and pDC–E2–E1-transfected
cells showed similar patterns of intense cytoplasmic fluo-isolation of RV particles was used (8). The culture fluid
(48 hr posttransfection) was clarified at 10,000 g for 10 rescent staining in the juxtanuclear region (Fig. 3). This
juxtanuclear region probably corresponded to Golgi com-min at 47C and 40% (w/v) PEG 6000 in Dulbecco’s mini-
mum essential medium was added to a final concentra- plexes as indicated by the costaining with WGA (data
not shown). Thus, mutant C and wild-type E2 and E1tion of 8% (w/v) (8). After incubation for 2 hr at 47, VLPs
were pelleted at 10,000 g for 45 min at 47 and resus- appeared to colocalize in Golgi compartments, similar
to their wild-type counterparts (Figs. 3A, 3C, and 3E).pended in lysis buffer (0.1 M sodium phosphate, pH 6, 5
mM EDTA, 0.1% (w/v) SDS, 1% (v/v) Nonidet P-40) for Cytoplasmic fluorescence staining was not detected in
mock-transfected or pCMV5-transfected cells (data notimmunoblot analysis using human anti-RV serum. It can
be seen that all three structural proteins were released shown). Previous studies have established that the accu-
mulation of capsid protein in the Golgi is dependent oninto the media of cells transfected with wild-type or mu-
tant cDNA (Fig. 2B, lanes 5 and 6). Under nonreducing the coexpression of E1 and E2, suggesting that spike
glycoproteins mediate the localization of capsid proteinconditions, the C2 dimers were observed in both the cell
lysate and in the media of cells transfected with wild- in the Golgi complex. From this study it appears that the
RV spike proteins are able to interact with and localizetype cDNA (Fig. 2B, lanes 2 and 5) but were not seen in
mutant capsid preparations (Fig. 2B, lanes 3 and 6). The monomeric mutant C proteins to the Golgi complex. Di-
merization of the capsid protein appears not to be re-capsid dimer was not present under reducing conditions
in both the cell lysate and VLP preparations (data not quired for this process. To determine whether the mutant
capsid protein affects the transport of E1 and E2 to theshown), indicating that C2 dimer formation was due to
disulfide linkages. Our results show that VLPs can form plasma membrane, mock-transfected, pCMV5-24S- or
pCMV5-DC–E2–E1-transfected COS cells were fixedin the presence of mutant C monomers and that dimeriza-
tion of the C protein is not necessary for particle forma- with 4% (w/v) paraformaldehyde for 30 min at room tem-
perature, reacted with mouse anti-E1 monoclonal anti-tion.
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FIG. 3. Indirect immunofluorescence of RV antigens in transfected COS cells. COS cells were transfected with pCMV5-24S (A, C, E, and G) or pCMV5-
DC–E2–E1 (B, D, F, and H) and fixed with acetone (0207) 48 hr later. The cells were reacted with human anti-RV serum (A, B), anti-E1 monoclonal
antibodies (C, D), or anti-C monoclonal antibodies (E, F) prior to staining with the appropriate FITC-conjugated IgG. For cell surface staining, cells were
treated with 4% (w/v) paraformaldehyde and reacted with anti-E1 monoclonal antibodies (G, H). Original magnifications of 4001 for all photomicrographs.
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bodies, and then treated with goat FITC-conjugated IgG not dependent on the dimerization of the capsid protein.
The presence of the VLPs in the medium of pCMV5-DC–to mouse (Dako). Cell surface fluorescent staining was
observed in both wild-type and mutant cell preparations E2–E1-transfected COS cells indicates that mutant VLPs
are stable. Disulfide linkages are usually formed to pro-(Figs. 3G and 3H) but was not observed in mock prepara-
tions (data not shown). Our results indicate that the E1 vide protein stability but it is not known whether there is
rearrangement of the core structure to accommodate forproteins are present on the cell surfaces of pCMV5-24S-
and pCMV5-DC–E2–E1-transfected COS cells. As previ- the lack of intermolecular bonding between the capsid
monomers. Thiol-disulfide exchange reactions are bio-ous studies have shown that the transport of E1 to the
cell surface is dependent on the presence of E2 (9), it was logically important for reducing and/or rearranging disul-
fide bridges in proteins. Further studies are needed toassumed that E2 was also present on the cell surface of
our transfected cell preparations. understand the reshuffling of disulfide bridges involved
in conformational changes in VLP formation.In this study we have found that capsid protein dimer-
ization does not appear to be important for the assembly
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